nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Sumatriptan—ABCB1—colon cancer	0.00387	0.553	CrCbGaD
Naratriptan—Eletriptan—ABCB1—colon cancer	0.00313	0.447	CrCbGaD
Naratriptan—Vaginal inflammation—Methotrexate—colon cancer	0.00226	0.00228	CcSEcCtD
Naratriptan—Cerebrovascular accident—Capecitabine—colon cancer	0.00225	0.00227	CcSEcCtD
Naratriptan—Cystitis noninfective—Methotrexate—colon cancer	0.00221	0.00222	CcSEcCtD
Naratriptan—Haemoglobin—Fluorouracil—colon cancer	0.00219	0.00221	CcSEcCtD
Naratriptan—Disturbance in sexual arousal—Capecitabine—colon cancer	0.00219	0.0022	CcSEcCtD
Naratriptan—Depressed level of consciousness—Methotrexate—colon cancer	0.00218	0.0022	CcSEcCtD
Naratriptan—Cystitis—Methotrexate—colon cancer	0.00218	0.0022	CcSEcCtD
Naratriptan—Haemorrhage—Fluorouracil—colon cancer	0.00218	0.0022	CcSEcCtD
Naratriptan—Cardiac disorder—Vincristine—colon cancer	0.00217	0.00219	CcSEcCtD
Naratriptan—Hypoaesthesia—Fluorouracil—colon cancer	0.00217	0.00219	CcSEcCtD
Naratriptan—Migraine—Capecitabine—colon cancer	0.00217	0.00219	CcSEcCtD
Naratriptan—Vaginal infection—Methotrexate—colon cancer	0.00213	0.00215	CcSEcCtD
Naratriptan—Angiopathy—Vincristine—colon cancer	0.00212	0.00214	CcSEcCtD
Naratriptan—Cardiac disorder—Irinotecan—colon cancer	0.00212	0.00213	CcSEcCtD
Naratriptan—Alopecia—Vincristine—colon cancer	0.00207	0.00208	CcSEcCtD
Naratriptan—Angiopathy—Irinotecan—colon cancer	0.00207	0.00208	CcSEcCtD
Naratriptan—Immune system disorder—Irinotecan—colon cancer	0.00206	0.00207	CcSEcCtD
Naratriptan—Dehydration—Capecitabine—colon cancer	0.00205	0.00206	CcSEcCtD
Naratriptan—Chills—Irinotecan—colon cancer	0.00204	0.00206	CcSEcCtD
Naratriptan—Urine output increased—Methotrexate—colon cancer	0.00204	0.00206	CcSEcCtD
Naratriptan—Bladder pain—Methotrexate—colon cancer	0.00204	0.00206	CcSEcCtD
Naratriptan—Arrhythmia—Irinotecan—colon cancer	0.00204	0.00205	CcSEcCtD
Naratriptan—Liver function test abnormal—Capecitabine—colon cancer	0.00204	0.00205	CcSEcCtD
Naratriptan—Dry skin—Capecitabine—colon cancer	0.00202	0.00204	CcSEcCtD
Naratriptan—Alopecia—Irinotecan—colon cancer	0.00201	0.00203	CcSEcCtD
Naratriptan—Gastritis—Capecitabine—colon cancer	0.00195	0.00197	CcSEcCtD
Naratriptan—Arrhythmia—Fluorouracil—colon cancer	0.00195	0.00196	CcSEcCtD
Naratriptan—Alopecia—Fluorouracil—colon cancer	0.00193	0.00194	CcSEcCtD
Naratriptan—Muscle spasms—Irinotecan—colon cancer	0.00191	0.00192	CcSEcCtD
Naratriptan—Asthma—Capecitabine—colon cancer	0.00191	0.00192	CcSEcCtD
Naratriptan—Erythema—Fluorouracil—colon cancer	0.0019	0.00191	CcSEcCtD
Naratriptan—Anaemia—Vincristine—colon cancer	0.00188	0.0019	CcSEcCtD
Naratriptan—Agitation—Vincristine—colon cancer	0.00187	0.00189	CcSEcCtD
Naratriptan—Photosensitivity—Methotrexate—colon cancer	0.00187	0.00188	CcSEcCtD
Naratriptan—Polyuria—Methotrexate—colon cancer	0.00187	0.00188	CcSEcCtD
Naratriptan—Angina pectoris—Capecitabine—colon cancer	0.00186	0.00187	CcSEcCtD
Naratriptan—Ill-defined disorder—Irinotecan—colon cancer	0.00184	0.00185	CcSEcCtD
Naratriptan—Anaemia—Irinotecan—colon cancer	0.00183	0.00185	CcSEcCtD
Naratriptan—Bronchitis—Capecitabine—colon cancer	0.00183	0.00185	CcSEcCtD
Naratriptan—Vertigo—Vincristine—colon cancer	0.00183	0.00184	CcSEcCtD
Naratriptan—Abdominal discomfort—Capecitabine—colon cancer	0.00183	0.00184	CcSEcCtD
Naratriptan—Vision blurred—Fluorouracil—colon cancer	0.00179	0.0018	CcSEcCtD
Naratriptan—Malaise—Irinotecan—colon cancer	0.00179	0.0018	CcSEcCtD
Naratriptan—Vertigo—Irinotecan—colon cancer	0.00178	0.00179	CcSEcCtD
Naratriptan—Syncope—Irinotecan—colon cancer	0.00178	0.00179	CcSEcCtD
Naratriptan—Convulsion—Vincristine—colon cancer	0.00176	0.00178	CcSEcCtD
Naratriptan—Anaemia—Fluorouracil—colon cancer	0.00176	0.00177	CcSEcCtD
Naratriptan—Loss of consciousness—Irinotecan—colon cancer	0.00174	0.00176	CcSEcCtD
Naratriptan—Photosensitivity reaction—Capecitabine—colon cancer	0.00174	0.00175	CcSEcCtD
Naratriptan—Myalgia—Vincristine—colon cancer	0.00173	0.00175	CcSEcCtD
Naratriptan—Cough—Irinotecan—colon cancer	0.00173	0.00174	CcSEcCtD
Naratriptan—Hyperglycaemia—Capecitabine—colon cancer	0.00172	0.00173	CcSEcCtD
Naratriptan—Pneumonia—Capecitabine—colon cancer	0.00171	0.00172	CcSEcCtD
Naratriptan—Anaphylactoid reaction—Methotrexate—colon cancer	0.0017	0.00171	CcSEcCtD
Naratriptan—Depression—Capecitabine—colon cancer	0.00169	0.00171	CcSEcCtD
Naratriptan—Acute coronary syndrome—Capecitabine—colon cancer	0.00167	0.00169	CcSEcCtD
Naratriptan—Cerebrovascular accident—Methotrexate—colon cancer	0.00167	0.00169	CcSEcCtD
Naratriptan—Discomfort—Irinotecan—colon cancer	0.00167	0.00168	CcSEcCtD
Naratriptan—Neuropathy peripheral—Capecitabine—colon cancer	0.00167	0.00168	CcSEcCtD
Naratriptan—Myocardial infarction—Capecitabine—colon cancer	0.00167	0.00168	CcSEcCtD
Naratriptan—Anaphylactic shock—Vincristine—colon cancer	0.00166	0.00167	CcSEcCtD
Naratriptan—Oedema—Vincristine—colon cancer	0.00166	0.00167	CcSEcCtD
Naratriptan—Infection—Vincristine—colon cancer	0.00165	0.00166	CcSEcCtD
Naratriptan—Convulsion—Fluorouracil—colon cancer	0.00165	0.00166	CcSEcCtD
Naratriptan—Confusional state—Irinotecan—colon cancer	0.00163	0.00164	CcSEcCtD
Naratriptan—Nervous system disorder—Vincristine—colon cancer	0.00163	0.00164	CcSEcCtD
Naratriptan—Thrombocytopenia—Vincristine—colon cancer	0.00163	0.00164	CcSEcCtD
Naratriptan—Anaphylactic shock—Irinotecan—colon cancer	0.00162	0.00163	CcSEcCtD
Naratriptan—Oedema—Irinotecan—colon cancer	0.00162	0.00163	CcSEcCtD
Naratriptan—Myalgia—Fluorouracil—colon cancer	0.00162	0.00163	CcSEcCtD
Naratriptan—Infection—Irinotecan—colon cancer	0.00161	0.00162	CcSEcCtD
Naratriptan—Hyperhidrosis—Vincristine—colon cancer	0.00161	0.00162	CcSEcCtD
Naratriptan—Discomfort—Fluorouracil—colon cancer	0.0016	0.00161	CcSEcCtD
Naratriptan—Shock—Irinotecan—colon cancer	0.00159	0.0016	CcSEcCtD
Naratriptan—Nervous system disorder—Irinotecan—colon cancer	0.00159	0.0016	CcSEcCtD
Naratriptan—Thrombocytopenia—Irinotecan—colon cancer	0.00159	0.0016	CcSEcCtD
Naratriptan—Hyperhidrosis—Irinotecan—colon cancer	0.00157	0.00158	CcSEcCtD
Naratriptan—Confusional state—Fluorouracil—colon cancer	0.00156	0.00157	CcSEcCtD
Naratriptan—Hypotension—Vincristine—colon cancer	0.00155	0.00156	CcSEcCtD
Naratriptan—Bradycardia—Capecitabine—colon cancer	0.00155	0.00156	CcSEcCtD
Naratriptan—Oedema—Fluorouracil—colon cancer	0.00155	0.00156	CcSEcCtD
Naratriptan—Anaphylactic shock—Fluorouracil—colon cancer	0.00155	0.00156	CcSEcCtD
Naratriptan—Infection—Fluorouracil—colon cancer	0.00154	0.00155	CcSEcCtD
Naratriptan—Haemoglobin—Capecitabine—colon cancer	0.00153	0.00154	CcSEcCtD
Naratriptan—Haemorrhage—Capecitabine—colon cancer	0.00153	0.00154	CcSEcCtD
Naratriptan—Nervous system disorder—Fluorouracil—colon cancer	0.00152	0.00153	CcSEcCtD
Naratriptan—Thrombocytopenia—Fluorouracil—colon cancer	0.00152	0.00153	CcSEcCtD
Naratriptan—Hypoaesthesia—Capecitabine—colon cancer	0.00152	0.00153	CcSEcCtD
Naratriptan—Liver function test abnormal—Methotrexate—colon cancer	0.00152	0.00153	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Vincristine—colon cancer	0.00151	0.00153	CcSEcCtD
Naratriptan—Hypotension—Irinotecan—colon cancer	0.00151	0.00152	CcSEcCtD
Naratriptan—Paraesthesia—Vincristine—colon cancer	0.00149	0.0015	CcSEcCtD
Naratriptan—Paraesthesia—Irinotecan—colon cancer	0.00145	0.00146	CcSEcCtD
Naratriptan—Hypotension—Fluorouracil—colon cancer	0.00145	0.00146	CcSEcCtD
Naratriptan—Dyspnoea—Irinotecan—colon cancer	0.00144	0.00145	CcSEcCtD
Naratriptan—Somnolence—Irinotecan—colon cancer	0.00144	0.00145	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Vincristine—colon cancer	0.00144	0.00145	CcSEcCtD
Naratriptan—Fatigue—Vincristine—colon cancer	0.00143	0.00144	CcSEcCtD
Naratriptan—Tinnitus—Capecitabine—colon cancer	0.00142	0.00143	CcSEcCtD
Naratriptan—Pain—Vincristine—colon cancer	0.00142	0.00143	CcSEcCtD
Naratriptan—Constipation—Vincristine—colon cancer	0.00142	0.00143	CcSEcCtD
Naratriptan—Asthma—Methotrexate—colon cancer	0.00142	0.00143	CcSEcCtD
Naratriptan—Cardiac disorder—Capecitabine—colon cancer	0.00142	0.00143	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00141	0.00142	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Irinotecan—colon cancer	0.0014	0.00141	CcSEcCtD
Naratriptan—Fatigue—Irinotecan—colon cancer	0.0014	0.00141	CcSEcCtD
Naratriptan—Paraesthesia—Fluorouracil—colon cancer	0.00139	0.0014	CcSEcCtD
Naratriptan—Pain—Irinotecan—colon cancer	0.00138	0.00139	CcSEcCtD
Naratriptan—Constipation—Irinotecan—colon cancer	0.00138	0.00139	CcSEcCtD
Naratriptan—Angiopathy—Capecitabine—colon cancer	0.00138	0.00139	CcSEcCtD
Naratriptan—Dyspnoea—Fluorouracil—colon cancer	0.00138	0.00139	CcSEcCtD
Naratriptan—Somnolence—Fluorouracil—colon cancer	0.00138	0.00139	CcSEcCtD
Naratriptan—Immune system disorder—Capecitabine—colon cancer	0.00138	0.00139	CcSEcCtD
Naratriptan—Chills—Capecitabine—colon cancer	0.00137	0.00138	CcSEcCtD
Naratriptan—Arrhythmia—Capecitabine—colon cancer	0.00136	0.00137	CcSEcCtD
Naratriptan—Abdominal discomfort—Methotrexate—colon cancer	0.00136	0.00137	CcSEcCtD
Naratriptan—Alopecia—Capecitabine—colon cancer	0.00135	0.00136	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00134	0.00135	CcSEcCtD
Naratriptan—Feeling abnormal—Irinotecan—colon cancer	0.00133	0.00134	CcSEcCtD
Naratriptan—Erythema—Capecitabine—colon cancer	0.00133	0.00134	CcSEcCtD
Naratriptan—Pain—Fluorouracil—colon cancer	0.00133	0.00134	CcSEcCtD
Naratriptan—Body temperature increased—Vincristine—colon cancer	0.00131	0.00132	CcSEcCtD
Naratriptan—Photosensitivity reaction—Methotrexate—colon cancer	0.00129	0.0013	CcSEcCtD
Naratriptan—Body temperature increased—Irinotecan—colon cancer	0.00128	0.00129	CcSEcCtD
Naratriptan—Feeling abnormal—Fluorouracil—colon cancer	0.00128	0.00129	CcSEcCtD
Naratriptan—Muscle spasms—Capecitabine—colon cancer	0.00128	0.00129	CcSEcCtD
Naratriptan—Pneumonia—Methotrexate—colon cancer	0.00127	0.00128	CcSEcCtD
Naratriptan—Drowsiness—Methotrexate—colon cancer	0.00126	0.00127	CcSEcCtD
Naratriptan—Depression—Methotrexate—colon cancer	0.00126	0.00127	CcSEcCtD
Naratriptan—Vision blurred—Capecitabine—colon cancer	0.00125	0.00126	CcSEcCtD
Naratriptan—Tremor—Capecitabine—colon cancer	0.00124	0.00125	CcSEcCtD
Naratriptan—Ill-defined disorder—Capecitabine—colon cancer	0.00123	0.00124	CcSEcCtD
Naratriptan—Urticaria—Fluorouracil—colon cancer	0.00123	0.00124	CcSEcCtD
Naratriptan—Anaemia—Capecitabine—colon cancer	0.00123	0.00124	CcSEcCtD
Naratriptan—Body temperature increased—Fluorouracil—colon cancer	0.00123	0.00123	CcSEcCtD
Naratriptan—Hypersensitivity—Vincristine—colon cancer	0.00122	0.00123	CcSEcCtD
Naratriptan—Sweating—Methotrexate—colon cancer	0.00121	0.00122	CcSEcCtD
Naratriptan—Malaise—Capecitabine—colon cancer	0.0012	0.00121	CcSEcCtD
Naratriptan—Vertigo—Capecitabine—colon cancer	0.00119	0.0012	CcSEcCtD
Naratriptan—Hypersensitivity—Irinotecan—colon cancer	0.00119	0.0012	CcSEcCtD
Naratriptan—Asthenia—Vincristine—colon cancer	0.00119	0.0012	CcSEcCtD
Naratriptan—Syncope—Capecitabine—colon cancer	0.00119	0.0012	CcSEcCtD
Naratriptan—Palpitations—Capecitabine—colon cancer	0.00117	0.00118	CcSEcCtD
Naratriptan—Loss of consciousness—Capecitabine—colon cancer	0.00117	0.00118	CcSEcCtD
Naratriptan—Asthenia—Irinotecan—colon cancer	0.00116	0.00117	CcSEcCtD
Naratriptan—Cough—Capecitabine—colon cancer	0.00116	0.00117	CcSEcCtD
Naratriptan—Hypersensitivity—Fluorouracil—colon cancer	0.00114	0.00115	CcSEcCtD
Naratriptan—Haemoglobin—Methotrexate—colon cancer	0.00114	0.00115	CcSEcCtD
Naratriptan—Diarrhoea—Vincristine—colon cancer	0.00114	0.00115	CcSEcCtD
Naratriptan—Haemorrhage—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Naratriptan—Myalgia—Capecitabine—colon cancer	0.00113	0.00114	CcSEcCtD
Naratriptan—Arthralgia—Capecitabine—colon cancer	0.00113	0.00114	CcSEcCtD
Naratriptan—Anxiety—Capecitabine—colon cancer	0.00113	0.00113	CcSEcCtD
Naratriptan—Discomfort—Capecitabine—colon cancer	0.00112	0.00112	CcSEcCtD
Naratriptan—Diarrhoea—Irinotecan—colon cancer	0.00111	0.00112	CcSEcCtD
Naratriptan—Dry mouth—Capecitabine—colon cancer	0.00111	0.00111	CcSEcCtD
Naratriptan—Dizziness—Vincristine—colon cancer	0.0011	0.00111	CcSEcCtD
Naratriptan—Pruritus—Fluorouracil—colon cancer	0.0011	0.0011	CcSEcCtD
Naratriptan—Confusional state—Capecitabine—colon cancer	0.00109	0.0011	CcSEcCtD
Naratriptan—Oedema—Capecitabine—colon cancer	0.00108	0.00109	CcSEcCtD
Naratriptan—Infection—Capecitabine—colon cancer	0.00108	0.00108	CcSEcCtD
Naratriptan—Dizziness—Irinotecan—colon cancer	0.00107	0.00108	CcSEcCtD
Naratriptan—Shock—Capecitabine—colon cancer	0.00107	0.00107	CcSEcCtD
Naratriptan—Nervous system disorder—Capecitabine—colon cancer	0.00106	0.00107	CcSEcCtD
Naratriptan—Diarrhoea—Fluorouracil—colon cancer	0.00106	0.00107	CcSEcCtD
Naratriptan—Thrombocytopenia—Capecitabine—colon cancer	0.00106	0.00107	CcSEcCtD
Naratriptan—Tinnitus—Methotrexate—colon cancer	0.00106	0.00107	CcSEcCtD
Naratriptan—Vomiting—Vincristine—colon cancer	0.00106	0.00106	CcSEcCtD
Naratriptan—Cardiac disorder—Methotrexate—colon cancer	0.00105	0.00106	CcSEcCtD
Naratriptan—Skin disorder—Capecitabine—colon cancer	0.00105	0.00106	CcSEcCtD
Naratriptan—Rash—Vincristine—colon cancer	0.00105	0.00106	CcSEcCtD
Naratriptan—Hyperhidrosis—Capecitabine—colon cancer	0.00105	0.00105	CcSEcCtD
Naratriptan—Dermatitis—Vincristine—colon cancer	0.00105	0.00105	CcSEcCtD
Naratriptan—Headache—Vincristine—colon cancer	0.00104	0.00105	CcSEcCtD
Naratriptan—Angiopathy—Methotrexate—colon cancer	0.00103	0.00104	CcSEcCtD
Naratriptan—Vomiting—Irinotecan—colon cancer	0.00103	0.00104	CcSEcCtD
Naratriptan—Immune system disorder—Methotrexate—colon cancer	0.00103	0.00103	CcSEcCtD
Naratriptan—Dizziness—Fluorouracil—colon cancer	0.00103	0.00103	CcSEcCtD
Naratriptan—Rash—Irinotecan—colon cancer	0.00102	0.00103	CcSEcCtD
Naratriptan—Dermatitis—Irinotecan—colon cancer	0.00102	0.00103	CcSEcCtD
Naratriptan—Chills—Methotrexate—colon cancer	0.00102	0.00103	CcSEcCtD
Naratriptan—Headache—Irinotecan—colon cancer	0.00101	0.00102	CcSEcCtD
Naratriptan—Hypotension—Capecitabine—colon cancer	0.00101	0.00102	CcSEcCtD
Naratriptan—Alopecia—Methotrexate—colon cancer	0.001	0.00101	CcSEcCtD
Naratriptan—Erythema—Methotrexate—colon cancer	0.000988	0.000995	CcSEcCtD
Naratriptan—Nausea—Vincristine—colon cancer	0.000988	0.000994	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000987	0.000994	CcSEcCtD
Naratriptan—Vomiting—Fluorouracil—colon cancer	0.000986	0.000993	CcSEcCtD
Naratriptan—Rash—Fluorouracil—colon cancer	0.000978	0.000985	CcSEcCtD
Naratriptan—Dermatitis—Fluorouracil—colon cancer	0.000977	0.000984	CcSEcCtD
Naratriptan—Paraesthesia—Capecitabine—colon cancer	0.000973	0.00098	CcSEcCtD
Naratriptan—Headache—Fluorouracil—colon cancer	0.000971	0.000978	CcSEcCtD
Naratriptan—Dyspnoea—Capecitabine—colon cancer	0.000966	0.000973	CcSEcCtD
Naratriptan—Nausea—Irinotecan—colon cancer	0.000962	0.000969	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Capecitabine—colon cancer	0.000936	0.000942	CcSEcCtD
Naratriptan—Fatigue—Capecitabine—colon cancer	0.000934	0.000941	CcSEcCtD
Naratriptan—Vision blurred—Methotrexate—colon cancer	0.000932	0.000938	CcSEcCtD
Naratriptan—Pain—Capecitabine—colon cancer	0.000927	0.000933	CcSEcCtD
Naratriptan—Constipation—Capecitabine—colon cancer	0.000927	0.000933	CcSEcCtD
Naratriptan—Nausea—Fluorouracil—colon cancer	0.000921	0.000928	CcSEcCtD
Naratriptan—Ill-defined disorder—Methotrexate—colon cancer	0.000917	0.000924	CcSEcCtD
Naratriptan—Anaemia—Methotrexate—colon cancer	0.000914	0.00092	CcSEcCtD
Naratriptan—Feeling abnormal—Capecitabine—colon cancer	0.000893	0.000899	CcSEcCtD
Naratriptan—Malaise—Methotrexate—colon cancer	0.000891	0.000898	CcSEcCtD
Naratriptan—Vertigo—Methotrexate—colon cancer	0.000888	0.000894	CcSEcCtD
Naratriptan—Cough—Methotrexate—colon cancer	0.000863	0.000869	CcSEcCtD
Naratriptan—Urticaria—Capecitabine—colon cancer	0.000861	0.000867	CcSEcCtD
Naratriptan—Body temperature increased—Capecitabine—colon cancer	0.000857	0.000863	CcSEcCtD
Naratriptan—Convulsion—Methotrexate—colon cancer	0.000856	0.000862	CcSEcCtD
Naratriptan—Myalgia—Methotrexate—colon cancer	0.000842	0.000847	CcSEcCtD
Naratriptan—Arthralgia—Methotrexate—colon cancer	0.000842	0.000847	CcSEcCtD
Naratriptan—Discomfort—Methotrexate—colon cancer	0.000831	0.000837	CcSEcCtD
Naratriptan—Confusional state—Methotrexate—colon cancer	0.000813	0.000819	CcSEcCtD
Naratriptan—Anaphylactic shock—Methotrexate—colon cancer	0.000807	0.000812	CcSEcCtD
Naratriptan—Infection—Methotrexate—colon cancer	0.000801	0.000807	CcSEcCtD
Naratriptan—Hypersensitivity—Capecitabine—colon cancer	0.000798	0.000804	CcSEcCtD
Naratriptan—Nervous system disorder—Methotrexate—colon cancer	0.000791	0.000797	CcSEcCtD
Naratriptan—Thrombocytopenia—Methotrexate—colon cancer	0.00079	0.000795	CcSEcCtD
Naratriptan—Skin disorder—Methotrexate—colon cancer	0.000784	0.000789	CcSEcCtD
Naratriptan—Hyperhidrosis—Methotrexate—colon cancer	0.00078	0.000785	CcSEcCtD
Naratriptan—Asthenia—Capecitabine—colon cancer	0.000777	0.000783	CcSEcCtD
Naratriptan—Pruritus—Capecitabine—colon cancer	0.000767	0.000772	CcSEcCtD
Naratriptan—Hypotension—Methotrexate—colon cancer	0.000754	0.000759	CcSEcCtD
Naratriptan—Diarrhoea—Capecitabine—colon cancer	0.000741	0.000747	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000735	0.00074	CcSEcCtD
Naratriptan—Paraesthesia—Methotrexate—colon cancer	0.000724	0.000729	CcSEcCtD
Naratriptan—Dyspnoea—Methotrexate—colon cancer	0.000719	0.000724	CcSEcCtD
Naratriptan—Somnolence—Methotrexate—colon cancer	0.000717	0.000722	CcSEcCtD
Naratriptan—Dizziness—Capecitabine—colon cancer	0.000717	0.000722	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Methotrexate—colon cancer	0.000696	0.000701	CcSEcCtD
Naratriptan—Fatigue—Methotrexate—colon cancer	0.000695	0.0007	CcSEcCtD
Naratriptan—Pain—Methotrexate—colon cancer	0.00069	0.000695	CcSEcCtD
Naratriptan—Vomiting—Capecitabine—colon cancer	0.000689	0.000694	CcSEcCtD
Naratriptan—Rash—Capecitabine—colon cancer	0.000683	0.000688	CcSEcCtD
Naratriptan—Dermatitis—Capecitabine—colon cancer	0.000683	0.000687	CcSEcCtD
Naratriptan—Headache—Capecitabine—colon cancer	0.000679	0.000684	CcSEcCtD
Naratriptan—Feeling abnormal—Methotrexate—colon cancer	0.000665	0.000669	CcSEcCtD
Naratriptan—Nausea—Capecitabine—colon cancer	0.000644	0.000648	CcSEcCtD
Naratriptan—Urticaria—Methotrexate—colon cancer	0.000641	0.000645	CcSEcCtD
Naratriptan—Body temperature increased—Methotrexate—colon cancer	0.000638	0.000642	CcSEcCtD
Naratriptan—Hypersensitivity—Methotrexate—colon cancer	0.000594	0.000599	CcSEcCtD
Naratriptan—Asthenia—Methotrexate—colon cancer	0.000579	0.000583	CcSEcCtD
Naratriptan—Pruritus—Methotrexate—colon cancer	0.000571	0.000575	CcSEcCtD
Naratriptan—Diarrhoea—Methotrexate—colon cancer	0.000552	0.000556	CcSEcCtD
Naratriptan—Dizziness—Methotrexate—colon cancer	0.000533	0.000537	CcSEcCtD
Naratriptan—Vomiting—Methotrexate—colon cancer	0.000513	0.000517	CcSEcCtD
Naratriptan—Rash—Methotrexate—colon cancer	0.000509	0.000512	CcSEcCtD
Naratriptan—Dermatitis—Methotrexate—colon cancer	0.000508	0.000512	CcSEcCtD
Naratriptan—Headache—Methotrexate—colon cancer	0.000505	0.000509	CcSEcCtD
Naratriptan—Nausea—Methotrexate—colon cancer	0.000479	0.000483	CcSEcCtD
